AvanSci Bio - Tissue-Dissection Technology


AvanSci Bio's technology includes the automated MilliSect instrument which reportedly enables a greater than 90% tumor enriched sample for molecular analysis. The system will be tested at select customer sites in 2015 as part of a broader development program for a future generation instrument.

AvanSci Bio's technology includes the automated MilliSect instrument which reportedly enables a greater than 90% tumor enriched sample for molecular analysis. The system will be tested at select customer sites in 2015 as part of a broader development...Show all

Company (Acquired)

Phone: 435-901-4516

Fax:

1290 W 2320 S
Suite D
Salt Lake City, 84119
Utah, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AvanSci Bio - Tissue-Dissection Technology $0M Dec 10, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AvanSci Bio - Tissue-Dissection Technology Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)